Profile data is unavailable for this security.
About the company
Aurisco Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of specialty active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The Company's main products are respiratory, cardiovascular, anti-infective and nervous system drugs, including flumethasone, fluticasone propionate, eplerenone, tenofovir, pregabalin and other APIs and intermediates. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)1.44bn
- Net income in CNY382.11m
- Incorporated1998
- Employees1.52k
- LocationAurisco Pharmaceutical Co LtdNo. 1 Longxing RoadBadu Industrial Park, Tiantai CountyTAIZHOU 317200ChinaCHN
- Phone+86 57 683170900
- Fax+86 57 683170900
- Websitehttps://www.aurisco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harbin Pharmaceutical Group Co., Ltd. | 15.90bn | 555.94m | 7.63bn | 9.85k | 13.47 | 1.51 | -- | 0.4801 | 0.2249 | 0.2249 | 6.44 | 2.00 | 1.14 | 6.05 | 3.49 | 1,613,254.00 | 4.40 | 0.7414 | 11.75 | 1.89 | 27.66 | 23.87 | 3.88 | 0.7294 | 1.08 | 68.41 | 0.4524 | 0.00 | 11.93 | 7.41 | -14.88 | 2.69 | -5.38 | -- |
North China Pharmaceutical Co Ltd | 10.12bn | 50.33m | 7.81bn | 10.16k | 155.08 | 1.46 | -- | 0.7716 | 0.0293 | 0.0293 | 5.90 | 3.11 | 0.4721 | 2.78 | 4.30 | 995,956.10 | 0.4856 | -0.2978 | 1.14 | -0.7042 | 29.56 | 35.73 | 1.03 | -0.5985 | 0.5403 | 1.54 | 0.6491 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
Aurisco Pharmaceutical Co Ltd | 1.44bn | 382.11m | 8.20bn | 1.52k | 21.63 | 3.94 | -- | 5.69 | 0.9328 | 0.9328 | 3.50 | 5.12 | 0.5744 | 1.15 | 5.11 | 947,099.20 | 15.19 | 12.40 | 19.04 | 14.33 | 58.12 | 51.26 | 26.44 | 23.05 | 1.33 | -- | 0.1447 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.28bn | 139.62m | 8.20bn | 1.81k | 58.72 | 5.27 | -- | 6.41 | 0.2852 | 0.2852 | 2.61 | 3.18 | 0.5043 | 0.6114 | 2.37 | 706,662.60 | 6.01 | -2.10 | 8.95 | -3.16 | 72.86 | 69.74 | 11.91 | -6.00 | 1.05 | 16.41 | 0.0597 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
Chongqing Genrix Biophrmctcl Co Ltd | 1.09m | -775.10m | 8.24bn | 547.00 | -- | 3.30 | -- | 7,552.93 | -2.11 | -2.11 | 0.003 | 6.81 | 0.0003 | 0.0628 | 53.97 | 1,995.17 | -20.89 | -- | -21.71 | -- | -214.22 | -- | -71,021.27 | -- | 20.06 | -- | 0.2053 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
Zhejiang Hisun Pharmaceutical Co., Ltd. | 9.56bn | -77.34m | 8.50bn | 8.06k | -- | 1.05 | -- | 0.8898 | -0.0788 | -0.0788 | 8.09 | 6.72 | 0.5421 | 3.36 | 4.06 | 1,185,368.00 | -0.5337 | 1.95 | -0.8961 | 3.77 | 38.03 | 40.58 | -0.9846 | 3.43 | 0.6209 | 2.46 | 0.397 | 26.07 | -13.82 | 0.3618 | -119.05 | -- | -31.58 | -- |
Changchun BCHT Biotechnology Co | 1.88bn | 527.23m | 9.06bn | 1.24k | 17.16 | 2.20 | -- | 4.81 | 1.28 | 1.28 | 4.56 | 9.96 | 0.394 | 0.7747 | 1.53 | 1,517,684.00 | 11.03 | 9.95 | 13.51 | 12.81 | 89.44 | 86.63 | 27.99 | 24.03 | 1.99 | -- | 0.0252 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
Data as of Sep 13 2024. Currency figures normalised to Aurisco Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 5.76m | 1.46% |
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 1.55m | 0.39% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.30m | 0.33% |
Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 941.30k | 0.24% |
Chang Xin Asset Management Co., Ltd.as of 31 Dec 2023 | 787.50k | 0.20% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 731.50k | 0.19% |
Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 598.60k | 0.15% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 180.90k | 0.05% |
Fuanda Fund Management Co., Ltd.as of 31 Dec 2023 | 124.40k | 0.03% |
Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 117.20k | 0.03% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.